Camurus
Sweden - LundBiotechnology
Focus: Camurus is a Swedish specialty biotech company focused on innovative delivery technologies and specialty medicines across endocrinology, oncology, and gastroenterology. The company operates at mid-cap scale with 201-500 employees and a public listing.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
201-500
Open Jobs
0
About Camurus
AI assessmentNot HiringNo open roles listed right now. Follow Camurus to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
episil
Stable
Post-LOE
Legacy product in late-stage pipeline, no current commercial traction data available.
Pipeline & Clinical Trials
Help build intelligence for Camurus
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.